[1]
M. Sajith, A. Thomas, J. J. Kothia, B. Chandrakar, A. Pawar, and M. D. Bargaje, “COST OF THERAPY INCURRED FOR TUBERCULOSIS PATIENTS RECEIVING DIRECTLY OBSERVED THERAPY (DOT)”, Int J Pharm Pharm Sci, vol. 7, no. 11, pp. 141–144, Oct. 2015.